Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/57612
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deniz, M. | - |
dc.contributor.author | Şenol, H. | - |
dc.contributor.author | Erat, T. | - |
dc.contributor.author | Ari, H.F. | - |
dc.contributor.author | Altug, Ü. | - |
dc.contributor.author | Kiral, E. | - |
dc.date.accessioned | 2024-07-28T17:17:40Z | - |
dc.date.available | 2024-07-28T17:17:40Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 1056-9103 | - |
dc.identifier.uri | https://doi.org/10.1097/IPC.0000000000001380 | - |
dc.identifier.uri | https://hdl.handle.net/11499/57612 | - |
dc.description.abstract | Background Much of the knowledge regarding pediatric healthcare-associated infections is based on studies conducted in adults. Here, we investigated clinical risk factors and etiologic organisms, focusing on antibiotic and antifungal resistance in pediatric patients with nosocomial bloodstream infections (nBSIs) in pediatric intensive care units (PICUs). Methods A retrospective evaluation was conducted on pediatric patients with nBSI in the PICUs of a tertiary referral hospital. Results A total of 69 nBSI episodes in 65 patients were observed during the study period. Of these, a total of 40 (57.97%) were caused by Gram-negative bacteria, 6 (8.7%) by Gram-positive bacteria, and 23 (33.33%) by Candida species. The rankings of Gram-negative bacteria were Klebsiella pneumoniae (37.5%), Acinetobacter baumannii (22.5%), and Serratia marcescens (12.5%). Carbapenem resistance was found to be common among K. pneumoniae (40%) and all Acinetobacter species. Most children (54.41%) had spent >28 days in the PICU at the time of diagnosis of nBSI. The presence of central venous catheters was significantly associated with fungal nBSI (P = 0.047). Conclusions A high rate of antimicrobial resistance was observed among pathogens. A central venous catheter was associated with fungemia in children hospitalized in PICUs. Prolonged hospital stay before the diagnosis of BSI and the use of medical devices were found to be common in fungal infections. © Wolters Kluwer Health, Inc. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams and Wilkins | en_US |
dc.relation.ispartof | Infectious Diseases in Clinical Practice | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | carbapenem resistant | en_US |
dc.subject | children | en_US |
dc.subject | fungemia | en_US |
dc.subject | nosocomial bloodstream infection | en_US |
dc.subject | amikacin | en_US |
dc.subject | amphotericin B | en_US |
dc.subject | ampicillin | en_US |
dc.subject | antibiotic agent | en_US |
dc.subject | carbapenem | en_US |
dc.subject | caspofungin | en_US |
dc.subject | cefepime | en_US |
dc.subject | ceftazidime | en_US |
dc.subject | cephalosporin | en_US |
dc.subject | ciprofloxacin | en_US |
dc.subject | cotrimoxazole | en_US |
dc.subject | echinocandin | en_US |
dc.subject | fluconazole | en_US |
dc.subject | flucytosine | en_US |
dc.subject | gentamicin | en_US |
dc.subject | imipenem | en_US |
dc.subject | piperacillin plus tazobactam | en_US |
dc.subject | procalcitonin | en_US |
dc.subject | vancomycin | en_US |
dc.subject | voriconazole | en_US |
dc.subject | Acinetobacter | en_US |
dc.subject | Acinetobacter baumannii | en_US |
dc.subject | antibiotic resistance | en_US |
dc.subject | antibiotic sensitivity | en_US |
dc.subject | antifungal resistance | en_US |
dc.subject | antifungal susceptibility | en_US |
dc.subject | antimicrobial therapy | en_US |
dc.subject | Article | en_US |
dc.subject | bacteremia | en_US |
dc.subject | bacterial infection | en_US |
dc.subject | blood culture | en_US |
dc.subject | bloodstream infection | en_US |
dc.subject | bradycardia | en_US |
dc.subject | Candida albicans | en_US |
dc.subject | Candida glabrata | en_US |
dc.subject | Candida parapsilosis | en_US |
dc.subject | Candida tropicalis | en_US |
dc.subject | cardiovascular disease | en_US |
dc.subject | catheter infection | en_US |
dc.subject | cerebral palsy | en_US |
dc.subject | child | en_US |
dc.subject | congenital heart disease | en_US |
dc.subject | congenital heart malformation | en_US |
dc.subject | data collection method | en_US |
dc.subject | demographics | en_US |
dc.subject | Enterobacter | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | ethics | en_US |
dc.subject | female | en_US |
dc.subject | fever | en_US |
dc.subject | Fisher exact test | en_US |
dc.subject | Gram negative bacterium | en_US |
dc.subject | Gram positive bacterium | en_US |
dc.subject | heart failure | en_US |
dc.subject | hospital infection | en_US |
dc.subject | hospitalization | en_US |
dc.subject | human | en_US |
dc.subject | hypotension | en_US |
dc.subject | hypothermia | en_US |
dc.subject | intensive care unit | en_US |
dc.subject | Klebsiella | en_US |
dc.subject | Klebsiella pneumoniae | en_US |
dc.subject | length of stay | en_US |
dc.subject | lung disease | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | methicillin resistance | en_US |
dc.subject | minimum inhibitory concentration | en_US |
dc.subject | mortality | en_US |
dc.subject | multidrug resistance | en_US |
dc.subject | mycosis | en_US |
dc.subject | pediatric patient | en_US |
dc.subject | postoperative care | en_US |
dc.subject | preschool child | en_US |
dc.subject | prevalence | en_US |
dc.subject | prospective study | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.subject | retrospective study | en_US |
dc.subject | risk factor | en_US |
dc.subject | sepsis | en_US |
dc.subject | septic shock | en_US |
dc.subject | Serratia (bacterium) | en_US |
dc.subject | Serratia marcescens | en_US |
dc.subject | skin flora | en_US |
dc.subject | Staphylococcus aureus | en_US |
dc.subject | statistical analysis | en_US |
dc.subject | statistically significant result | en_US |
dc.subject | tertiary care center | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | urinary tract infection | en_US |
dc.title | The Etiologic Organisms, Risk Factors, and Outcomes of Nosocomial Bloodstream Infections in Pediatric Patients | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.issue | 4 | en_US |
dc.department | Pamukkale University | en_US |
dc.identifier.doi | 10.1097/IPC.0000000000001380 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57217489798 | - |
dc.authorscopusid | 56345836900 | - |
dc.authorscopusid | 57190489047 | - |
dc.authorscopusid | 57382236000 | - |
dc.authorscopusid | 57194008985 | - |
dc.authorscopusid | 57188589045 | - |
dc.identifier.scopus | 2-s2.0-85198311106 | en_US |
dc.identifier.wos | WOS:001267497900010 | en_US |
dc.institutionauthor | … | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.